Clinical Scorecard: Correction Notice: Combining Digital Gait Analysis with Metabolomics and Clinical Data for Predicting Outcomes in Parkinson's Disease
At a Glance
Category
Detail
Condition
Parkinson's Disease
Key Mechanisms
Integration of digital gait analysis, metabolomics, and clinical data
Target Population
Patients with Parkinson's Disease
Care Setting
Neurology and specialized clinical research centers
Key Highlights
Correction includes addition of consortium members meeting authorship criteria.
Original article integrates digital gait data with metabolomics and clinical data for outcome prediction.
Research conducted by multidisciplinary teams across multiple European institutions.
Guideline-Based Recommendations
Diagnosis
Utilize digital gait analysis combined with metabolomics and clinical data to enhance prediction of Parkinson's disease outcomes.
Management
Incorporate multidisciplinary data integration approaches for personalized patient management.
Monitoring & Follow-up
Employ digital gait metrics alongside biochemical markers for ongoing disease progression assessment.
Risks
No specific risks detailed in the correction notice.
Patient & Prescribing Data
Individuals diagnosed with Parkinson's Disease involved in clinical research settings.
The article focuses on predictive analytics rather than direct prescribing data.
Clinical Best Practices
Collaborate across neurology, bioinformatics, and metabolomics disciplines for comprehensive patient evaluation.
Apply advanced digital tools for gait analysis to supplement clinical assessments.
Ensure accurate authorship and contributor recognition in collaborative research.
